Inventor · disambiguated record
Revati J. Tatake
Also filed as: TATAKE REVATI J
4 granted patents·6 pending applications·23 citations·filing 1998–2010
71Inventor score
Top patents by PatentIndex Score
10 records- 0181US7829664B2Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereofBOEHRINGER INGELHEIM INT·Filed 2007·Granted Nov 9, 2010·14 cites·11 claims
- 0256US2009110669A1Methods for improving cell line activity in immunoisolation devicesBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 0349US7045346B2Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell linesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted May 16, 2006·0 cites·23 claims
- 0449US2003012772A1Methods for improving cell line activity in immunoisolation devicesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 0547US2006029584A1Methods for improving cell line activity in immunoisolation devicesBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 0646US6537784B1Self-regulated apoptosis of inflammatory cells by gene therapyBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Mar 25, 2003·8 cites·11 claims
- 0745US2004039186A1Self-regulated apoptosis of inflammatory cells by gene therapyBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 0841US2007009498A1Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell linesBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 0932US2011076257A1Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use ThereofTATAKE REVATI J·Filed 2010·Application pending·0 cites
- 1030US6525184B1Self-regulated apoptosis of inflammatory cellsBOEHRINGER INGELHEIM PHARMA·Filed 1998·Granted Feb 25, 2003·1 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Revati J. Tatake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →